drugset / Trial / NCT07291375
Role of Amlodipine in Reduction of CIN
RandomizedParallel-groupSingle-blindPrevention
Summary
The aim is to assess the benefit of low dose oral amlodipine in renal protection from contrast induced nephropathy in diabetic patients in intensive care unit
Timeline
- Start
- 2025-12-20
- Primary completion
- 2026-06-01
- Completion
- 2026-07-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amlodipine | Other / unclassified | 5 mg | Oral |
Indications
No indication recorded.